var data={"title":"Mallory-Weiss syndrome","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Mallory-Weiss syndrome</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/contributors\" class=\"contributor contributor_credentials\">Moises Guelrud, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/contributors\" class=\"contributor contributor_credentials\">John R Saltzman, MD, FACP, FACG, FASGE, AGAF</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/contributors\" class=\"contributor contributor_credentials\">Shilpa Grover, MD, MPH, AGAF</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jun 05, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Mallory-Weiss syndrome is characterized by longitudinal mucosal lacerations (intramural dissection) in the distal esophagus and proximal stomach, which are usually associated with forceful retching [<a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/1\" class=\"abstract_t\">1</a>]. The lacerations often lead to bleeding from submucosal arteries. This topic will review the epidemiology, pathogenesis, clinical manifestations, diagnosis, and management of Mallory-Weiss syndrome. The management of other causes of upper gastrointestinal bleeding and esophageal perforation are discussed in detail, separately. (See <a href=\"topic.htm?path=causes-of-upper-gastrointestinal-bleeding-in-adults\" class=\"medical medical_review\">&quot;Causes of upper gastrointestinal bleeding in adults&quot;</a> and <a href=\"topic.htm?path=boerhaave-syndrome-effort-rupture-of-the-esophagus\" class=\"medical medical_review\">&quot;Boerhaave syndrome: Effort rupture of the esophagus&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1951666247\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The reported incidence of Mallory-Weiss syndrome among patients presenting with upper gastrointestinal bleeding ranges from 8 to 15 percent [<a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/2-4\" class=\"abstract_t\">2-4</a>]. It is likely that Mallory-Weiss syndrome occurs in a less severe form more frequently than is recognized. However, the incidence of Mallory-Weiss tear in patients without overt gastrointestinal bleeding is not well established [<a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/5,6\" class=\"abstract_t\">5,6</a>]. </p><p class=\"headingAnchor\" id=\"H2568211429\"><span class=\"h1\">ETIOLOGY AND PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pathogenesis of Mallory-Weiss syndrome is not completely understood. It has been proposed that mucosal lacerations develop secondary to a sudden increase in intraabdominal pressure. Bleeding occurs when the tear involves the underlying esophageal venous or arterial plexus. Observational studies have identified certain clinical and demographic features as potential risk factors, although these are not all consistently found in all studies [<a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/4,7-15\" class=\"abstract_t\">4,7-15</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Alcohol use</strong>&mdash; A history of heavy alcohol use leading to vomiting has been noted in 40 to 80 percent of patients with Mallory-Weiss syndrome in case series [<a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/4,8-11\" class=\"abstract_t\">4,8-11</a>]. The bleeding is usually more severe when Mallory-Weiss tears are associated with portal hypertension and esophageal varices [<a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/12,13\" class=\"abstract_t\">12,13</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Hiatal</strong> <strong>hernia</strong> &mdash; It is unclear if hiatal hernia is a risk factor for Mallory-Weiss syndrome. It has been proposed that retching increases the potential for mucosal laceration by creating a higher pressure gradient in the hiatus hernia as compared with the rest of the stomach. Although a hiatus hernia has been reported in 40 to 80 percent of patients with Mallory-Weiss tears in some case series, a large case-control study found no significant difference in the prevalence of hiatus hernia among patients with Mallory-Weiss syndrome and controls [<a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/8,14\" class=\"abstract_t\">8,14</a>]. (See <a href=\"topic.htm?path=hiatus-hernia\" class=\"medical medical_review\">&quot;Hiatus hernia&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Age</strong> &mdash; Increasing age has been advocated as a predisposing factor of Mallory-Weiss tears [<a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/7\" class=\"abstract_t\">7</a>]. However, most tears occur in patients under the age of 40, suggesting that age does not play a major role. Tears have also occurred in children as young as three weeks of age [<a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/15\" class=\"abstract_t\">15</a>].</p><p/><p>Precipitating factors include vomiting, straining or lifting, coughing, seizures, blunt abdominal injury, nasogastric tube placement, and gastroscopy [<a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/2-5,7,16-18\" class=\"abstract_t\">2-5,7,16-18</a>]. </p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients usually present with acute onset of gastrointestinal bleeding with hematemesis (either red blood or coffee-ground emesis). Hematemesis may be accompanied by epigastric pain or pain in the back. Patients often have a history of nonbloody emesis, retching, or coughing prior to hematemesis [<a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/9\" class=\"abstract_t\">9</a>]. Patients with significant bleeding may have signs of hypovolemia and hemodynamic instability (eg, resting tachycardia, hypotension). </p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Mallory-Weiss syndrome should be suspected in patients with upper gastrointestinal bleeding and a history of vomiting or retching. An upper endoscopy establishes the diagnosis, rules out other etiologies, and allows for therapeutic intervention.</p><p class=\"headingAnchor\" id=\"H2751608317\"><span class=\"h2\">Upper endoscopy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Mallory-Weiss tears are located in the esophagogastric junction, often within a hiatal hernia; they usually extend downward into the cardia and sometimes upward into the esophagus [<a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/10\" class=\"abstract_t\">10</a>]. Mallory-Weiss tears are usually single and longitudinal. However, multiple mucosal tears have been found in up to 27 percent of cases [<a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/10,11\" class=\"abstract_t\">10,11</a>]. On endoscopy, the tears typically appear as a red longitudinal break in the mucosa (<a href=\"image.htm?imageKey=GAST%2F57049\" class=\"graphic graphic_picture graphicRef57049 \">picture 1</a>), sometimes extending through the muscularis mucosa (<a href=\"image.htm?imageKey=GAST%2F76980\" class=\"graphic graphic_picture graphicRef76980 \">picture 2</a>), and occasionally covered by a clot (<a href=\"image.htm?imageKey=GAST%2F68239\" class=\"graphic graphic_picture graphicRef68239 \">picture 3</a>). Active bleeding may also be noted (<a href=\"image.htm?imageKey=GAST%2F71690\" class=\"graphic graphic_picture graphicRef71690 \">picture 4</a>). In many instances, the lesions are recognized only after retroflexion of the tip of the gastroscope to view the cardia from below. Most tears heal significantly within 24 to 48 hours in patients without portal hypertension and may be missed if endoscopy is delayed.</p><p class=\"headingAnchor\" id=\"H3896917148\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of Mallory-Weiss syndrome includes other diseases of the esophagus that causes esophageal ulcers (eg, reflux, medication and infections). Mallory-Weiss syndrome can be distinguished from these by history and upper endoscopy. </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Reflux esophagitis </strong>&mdash; Patients often have a history of heartburn (pyrosis), regurgitation, and <span class=\"nowrap\">dysphagia/odynophagia</span>. The ulcerations seen in reflux esophagitis are usually in the distal esophagus, but unlike Mallory-Weiss tears, ulcers may be irregularly shaped and multiple. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-gastroesophageal-reflux-in-adults#H7\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of gastroesophageal reflux in adults&quot;, section on 'Upper gastrointestinal endoscopy'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Medication-induced esophagitis</strong> &mdash; Medication-induced esophagitis is suspected by the history (eg, use of a drug such as <a href=\"topic.htm?path=tetracycline-drug-information\" class=\"drug drug_general\">tetracycline</a> or <a href=\"topic.htm?path=alendronate-drug-information\" class=\"drug drug_general\">alendronate</a>). Medication-induced ulcerations are usually singular and deep, occurring at points of stasis (especially near the carina), with sparing of the distal esophagus. (See <a href=\"topic.htm?path=medication-induced-esophagitis#H6\" class=\"medical medical_review\">&quot;Medication-induced esophagitis&quot;, section on 'Diagnosis'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Infectious esophagitis</strong> &mdash; Infectious esophagitis is circumferential and tends to involve the proximal esophagus. Ulcers are multiple and punctate. In patients with herpes simplex virus esophagitis, ulcers in the distal esophagus are well circumscribed and have a &quot;volcano-like&quot; appearance. In patients with cytomegalovirus infection, ulcers tend to be linear or longitudinal and deep. The diagnosis of infectious esophagitis is established by biopsies or brushing ideally taken from the edge of an ulcer. (See <a href=\"topic.htm?path=herpes-simplex-virus-infection-of-the-esophagus#H6\" class=\"medical medical_review\">&quot;Herpes simplex virus infection of the esophagus&quot;, section on 'Diagnosis'</a>.)</p><p/><p>Other causes of upper gastrointestinal bleeding are discussed in detail separately. (See <a href=\"topic.htm?path=causes-of-upper-gastrointestinal-bleeding-in-adults#H8623583\" class=\"medical medical_review\">&quot;Causes of upper gastrointestinal bleeding in adults&quot;, section on 'Specific causes'</a>.)</p><p class=\"headingAnchor\" id=\"H3605213667\"><span class=\"h1\">INITIAL MANAGEMENT</span></p><p class=\"headingAnchor\" id=\"H1760946791\"><span class=\"h2\">Overview</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The initial evaluation of a patient with upper gastrointestinal bleeding starts with assessing hemodynamic stability and determining the need for fluid resuscitation <span class=\"nowrap\">and/or</span> blood transfusion. This part of the evaluation is discussed in detail elsewhere. (See <a href=\"topic.htm?path=approach-to-acute-upper-gastrointestinal-bleeding-in-adults\" class=\"medical medical_review\">&quot;Approach to acute upper gastrointestinal bleeding in adults&quot;</a>.)</p><p>Patients with clinically significant upper gastrointestinal bleeding (ie, signs of active upper gastrointestinal bleeding including hematemesis, melena, or hematochezia, with or without hemodynamic instability or blood transfusion requirement) should be started on a twice-daily intravenous (IV) proton pump inhibitor (PPI) prior to endoscopy as part of their initial management. (See <a href=\"topic.htm?path=approach-to-acute-upper-gastrointestinal-bleeding-in-adults#H5079756\" class=\"medical medical_review\">&quot;Approach to acute upper gastrointestinal bleeding in adults&quot;, section on 'Acid suppression'</a>.)</p><p>Once the patient is stabilized, endoscopy is performed for diagnosis and potential treatment. Mallory-Weiss tears that are actively bleeding (spurting or oozing hemorrhage) require endoscopic therapy. Mallory-Weiss tears that are not actively bleeding can be managed with acid suppression alone. We reserve the use of antiemetics for patients with Mallory-Weiss syndrome who have persistent nausea or vomiting. (See <a href=\"#H3045402223\" class=\"local\">'Endoscopic therapy for patients with active bleeding'</a> below and <a href=\"#H2647541781\" class=\"local\">'Acid suppression'</a> below and <a href=\"#H4074434499\" class=\"local\">'Antiemetics'</a> below.)</p><p class=\"headingAnchor\" id=\"H3045770783\"><span class=\"h2\">Inpatient versus outpatient management</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We typically hospitalize and observe patients at high risk for rebleeding and its complications for a minimum of 48 hours. This includes patients with any one of the following:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Risk factors for recurrent bleeding (active bleeding at the time of endoscopy, portal hypertension coagulopathy).</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Endoscopic stigmata of recent bleeding (eg, nonbleeding visible vessel or adherent clot).</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Severe upper gastrointestinal bleeding (hemodynamic instability, hematochezia, blood transfusion requirement).</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Increased risk for complications should bleeding recur (eg, significant coronary artery or cerebrovascular disease, age over 65 years, patients taking antiplatelet or anticoagulant medications). </p><p/><p>Risk stratification scores can help differentiate patients who require hospitalization from those who are appropriate for outpatient management [<a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/19,20\" class=\"abstract_t\">19,20</a>]. It is recommended in the International Consensus Recommendations that all patients with upper gastrointestinal bleeding undergo risk stratification using a validated prognostic scale such as the Rockall score (<a href=\"topic.htm?path=calculator-rockall-score-for-upper-gastrointestinal-bleeding-in-adults\" class=\"calc calc_professional\">calculator 1</a>), Blatchford score (<a href=\"topic.htm?path=calculator-blatchford-score-for-gastrointestinal-bleeding-in-adults\" class=\"calc calc_professional\">calculator 2</a>) or AIMS65 score [<a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/21\" class=\"abstract_t\">21</a>]. (See <a href=\"topic.htm?path=approach-to-acute-upper-gastrointestinal-bleeding-in-adults#H11\" class=\"medical medical_review\">&quot;Approach to acute upper gastrointestinal bleeding in adults&quot;, section on 'Risk stratification'</a>.)</p><p>Patients without risk factors for rebleeding, evidence of severe upper gastrointestinal bleeding, or endoscopic stigmata of recent bleeding can be discharged from the hospital on oral antisecretory therapy once the effects of procedural sedation have worn off, provided that the patient is reliable and can promptly get medical care should bleeding recur. </p><p class=\"headingAnchor\" id=\"H4271639672\"><span class=\"h2\">Pharmacologic therapy for all patients</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pharmacologic therapy for Mallory-Weiss syndrome includes acid suppression with PPI and antiemetics. </p><p class=\"headingAnchor\" id=\"H2647541781\"><span class=\"h3\">Acid suppression</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In general, a twice-daily IV PPI should be given to all patients with suspected clinically significant upper gastrointestinal bleeding prior to endoscopy as part of their initial management. (See <a href=\"topic.htm?path=approach-to-acute-upper-gastrointestinal-bleeding-in-adults#H5079756\" class=\"medical medical_review\">&quot;Approach to acute upper gastrointestinal bleeding in adults&quot;, section on 'Acid suppression'</a>.)</p><p>The twice-daily IV PPI may be switched to a standard-dose oral PPI (eg, <a href=\"topic.htm?path=omeprazole-drug-information\" class=\"drug drug_general\">omeprazole</a> 20 mg daily) following endoscopy. We continue oral PPI therapy for two weeks to stabilize the clot and accelerate mucosal healing. PPIs may promote hemostasis by neutralizing gastric acid and stabilizing blood clots. However, the efficacy of PPI therapy for preventing rebleeding in Mallory-Weiss syndrome has not been well-studied. (See <a href=\"topic.htm?path=overview-of-the-treatment-of-bleeding-peptic-ulcers#H57224576\" class=\"medical medical_review\">&quot;Overview of the treatment of bleeding peptic ulcers&quot;, section on 'Efficacy of proton pump inhibitors'</a>.)</p><p class=\"headingAnchor\" id=\"H4074434499\"><span class=\"h3\">Antiemetics</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Antiemetics (eg, <a href=\"topic.htm?path=metoclopramide-drug-information\" class=\"drug drug_general\">metoclopramide</a>, <a href=\"topic.htm?path=prochlorperazine-drug-information\" class=\"drug drug_general\">prochlorperazine</a>) are reserved for patients with persistent nausea or vomiting. (See <a href=\"topic.htm?path=approach-to-the-adult-with-nausea-and-vomiting#H25\" class=\"medical medical_review\">&quot;Approach to the adult with nausea and vomiting&quot;, section on 'Treatment'</a>.)</p><p class=\"headingAnchor\" id=\"H3045402223\"><span class=\"h2\">Endoscopic therapy for patients with active bleeding</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Endoscopic therapy is indicated for treatment of actively bleeding (spurting or oozing hemorrhage) Mallory-Weiss tears. Patients may be treated with thermal coagulation, hemoclips, or endoscopic band ligation (with or without <a href=\"topic.htm?path=epinephrine-adrenaline-drug-information\" class=\"drug drug_general\">epinephrine</a> injection) but should not be treated with epinephrine monotherapy due to an increased risk of recurrent bleeding [<a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/17,22-30\" class=\"abstract_t\">17,22-30</a>]. The choice between hemoclips, endoscopic band ligation, and thermal therapy will often depend upon the preference of the endoscopist and the presence of underlying portal hypertension or esophageal varices. In patients with portal hypertension or esophageal varices, endoscopic band ligation should be performed as thermal coagulation may precipitate or worsen bleeding. </p><p>The technique for thermal coagulation is generally similar to that used in patients with peptic ulcer bleeding. However, coagulation should be performed with less tamponade force and lower total energy (eg, bipolar probe at 15 watts, mild tamponade, and one second pulses) in patients with Mallory-Weiss syndrome as the esophagus lacks a serosa and may be very thin at the tear site and the underlying artery is small. Repeated coagulation should be avoided because of the risk of transmural injury and perforation [<a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/31\" class=\"abstract_t\">31</a>]. The technique for hemoclips, endoscopic band ligation, and injection with <a href=\"topic.htm?path=epinephrine-adrenaline-drug-information\" class=\"drug drug_general\">epinephrine</a> are similar to patients with peptic ulcer bleeding. Detailed discussions of the endoscopic techniques used for hemostasis are presented elsewhere. (See <a href=\"topic.htm?path=contact-thermal-devices-for-the-treatment-of-bleeding-peptic-ulcers\" class=\"medical medical_review\">&quot;Contact thermal devices for the treatment of bleeding peptic ulcers&quot;</a> and <a href=\"topic.htm?path=endoclip-therapy-in-the-gastrointestinal-tract-bleeding-lesions-and-beyond\" class=\"medical medical_review\">&quot;Endoclip therapy in the gastrointestinal tract: Bleeding lesions and beyond&quot;</a> and <a href=\"topic.htm?path=overview-of-the-treatment-of-bleeding-peptic-ulcers#H97407324\" class=\"medical medical_review\">&quot;Overview of the treatment of bleeding peptic ulcers&quot;, section on 'Injection therapy'</a>.)</p><p>Few studies have directly compared these modalities [<a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/19,25,32\" class=\"abstract_t\">19,25,32</a>]. In a randomized trial in which 41 patients with actively bleeding Mallory-Weiss tears were assigned to endoscopic band ligation or hemoclip placement, there were no differences in the rates of primary hemostasis or rebleeding between the two groups [<a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/32\" class=\"abstract_t\">32</a>]. In a retrospective study that included 168 patients with Mallory-Weiss tear, hemoclip-based therapy and band ligation were associated with higher success rates in preventing rebleeding as compared with injection therapy alone (96, 89 and 71 percent, respectively) [<a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/19\" class=\"abstract_t\">19</a>]. (See <a href=\"topic.htm?path=endoscopic-variceal-ligation\" class=\"medical medical_review\">&quot;Endoscopic variceal ligation&quot;</a>.)</p><p>Injection of sclerosing agents (eg, ethanol, <a href=\"topic.htm?path=polidocanol-drug-information\" class=\"drug drug_general\">polidocanol</a>) can be effective in achieving hemostasis in patients with Mallory-Weiss syndrome [<a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/31,33,34\" class=\"abstract_t\">31,33,34</a>]. However, sclerosing agents are not widely used due to the risk of deep tissue necrosis and perforation. </p><p class=\"headingAnchor\" id=\"H3881341551\"><span class=\"h1\">TREATMENT OF PERSISTENT AND RECURRENT BLEEDING</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The majority of patients with Mallory-Weiss syndrome can be controlled endoscopically. Approximately 7 percent have recurrent bleeding. Rebleeding in patients with Mallory-Weiss syndrome usually occurs within 24 hours of the initial episode [<a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/35\" class=\"abstract_t\">35</a>]. If feasible, we perform a repeat upper endoscopy in patients with rebleeding.</p><p>We suggest that patients who have failed endoscopic therapy undergo attempted angiography with transarterial embolization (TAE), and that surgery with oversewing of the bleeding vessel be reserved for those who fail angiographic therapy [<a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/2,4,36\" class=\"abstract_t\">2,4,36</a>]. However, surgery is a reasonable alternative if an interventional radiologist with expertise in TAE is not available, if the lesion is deemed unlikely to respond to angiographic therapy, or if the patient has underlying conditions that may complicate the ability to perform angiography or TAE (eg, renal insufficiency). (See <a href=\"topic.htm?path=angiographic-control-of-nonvariceal-gastrointestinal-bleeding-in-adults\" class=\"medical medical_review\">&quot;Angiographic control of nonvariceal gastrointestinal bleeding in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3537167\"><span class=\"h1\">PROGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Mallory-Weiss syndrome tears heal rapidly in the absence of portal hypertensive gastropathy. Patients do not require repeat endoscopic evaluation to document healing. Approximately 7 percent of patients have recurrent bleeding which usually occurs within 24 hours of the initial episode. Approximately 40 to 70 percent of patients with bleeding Mallory-Weiss syndrome require blood transfusions [<a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/18,37\" class=\"abstract_t\">18,37</a>]. Active bleeding at the time of initial endoscopy and a low initial hematocrit have been associated with a higher rate of rebleeding, need for angiography or surgery, or death [<a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/38\" class=\"abstract_t\">38</a>]. The mortality rate is approximately 5 percent and depends upon patient age and the presence of coexisting medical conditions. A retrospective study comparing the 30-day mortality in 281 patients with endoscopically confirmed Mallory-Weiss syndrome and 1530 patients with peptic ulcer bleeding found that the mortality rate was 5.3 percent for patients with bleeding Mallory-Weiss syndrome and 4.6 percent for patients with peptic ulcer bleeding [<a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/39\" class=\"abstract_t\">39</a>]. In both patients with bleeding Mallory-Weiss syndrome and peptic ulcer bleeding, mortality was significantly higher in patients over 65 years of age and those with significant overall comorbidities.</p><p class=\"headingAnchor\" id=\"H1986206053\"><span class=\"h1\">RESUMPTION OF ANTICOAGULANTS AND ANTIPLATELET AGENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Data are limited with regard to the appropriate timing for resuming anticoagulation or antiplatelet agents following endoscopic hemostasis. The timing will depend on the patient's risk of suffering a thromboembolic event while off of the medication(s). When to resume these agents after hemostasis has been achieved is discussed elsewhere. (See <a href=\"topic.htm?path=management-of-anticoagulants-in-patients-undergoing-endoscopic-procedures#H15\" class=\"medical medical_review\">&quot;Management of anticoagulants in patients undergoing endoscopic procedures&quot;, section on 'Resumption of anticoagulants'</a> and <a href=\"topic.htm?path=management-of-antiplatelet-agents-in-patients-undergoing-endoscopic-procedures#H9\" class=\"medical medical_review\">&quot;Management of antiplatelet agents in patients undergoing endoscopic procedures&quot;, section on 'Urgent procedures in patients on antiplatelet agents'</a>.)</p><p class=\"headingAnchor\" id=\"H3260238603\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-gastrointestinal-bleeding-in-adults\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Gastrointestinal bleeding in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mallory-Weiss syndrome is characterized by longitudinal mucosal lacerations (intramural dissections) in the distal esophagus and proximal stomach secondary to a sudden increase in intraabdominal pressure. Bleeding occurs when the tear involves the underlying esophageal venous or arterial plexus. Potential risk factors include alcohol use and hiatus hernia. Mallory-Weiss syndrome may be precipitated by vomiting, straining or lifting, coughing, seizures, blunt abdominal injury, nasogastric tube placement, and gastroscopy. (See <a href=\"#H1951666247\" class=\"local\">'Epidemiology'</a> above and <a href=\"#H2568211429\" class=\"local\">'Etiology and pathogenesis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Acute gastrointestinal bleeding is the major clinical manifestation of Mallory-Weiss syndrome and may be accompanied by epigastric pain or pain in the back. Patients often have a history of nonbloody vomiting or retching before the onset of hematemesis. (See <a href=\"#H6\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The initial evaluation of the patient with upper gastrointestinal bleeding involves an assessment of hemodynamic stability and the necessity for fluid resuscitation. In general, a twice-daily intravenous proton pump inhibitor (PPI) is administered to all patients with suspected clinically significant upper gastrointestinal bleeding prior to endoscopy as part of their initial management. (See <a href=\"topic.htm?path=approach-to-acute-upper-gastrointestinal-bleeding-in-adults#H5079756\" class=\"medical medical_review\">&quot;Approach to acute upper gastrointestinal bleeding in adults&quot;, section on 'Acid suppression'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of Mallory-Weiss syndrome should be suspected in patients with upper gastrointestinal bleeding and a history of vomiting or retching. An upper endoscopy establishes the diagnosis, rules out other etiologies, and allows for therapeutic intervention. (See <a href=\"#H7\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In patients with active bleeding (oozing or spurting) from a Mallory-Weiss tear, we recommend endoscopic therapy and acid suppressive therapy rather than acid suppressive therapy alone (<a href=\"grade.htm?i=2\" class=\"grade\">Grade 1B</a>). Patients may be treated with thermal coagulation, hemoclips, or endoscopic band ligation (with or without <a href=\"topic.htm?path=epinephrine-adrenaline-drug-information\" class=\"drug drug_general\">epinephrine</a> injection) but should not be treated with epinephrine monotherapy due to an increased risk of recurrent bleeding. Mallory-Weiss tears that are not actively bleeding at the time of endoscopy can be managed with acid suppression alone. We continue standard-dose oral PPI (eg, <a href=\"topic.htm?path=omeprazole-drug-information\" class=\"drug drug_general\">omeprazole</a> 20 mg daily) therapy for two weeks. (See <a href=\"#H1760946791\" class=\"local\">'Overview'</a> above and <a href=\"#H2647541781\" class=\"local\">'Acid suppression'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>We typically hospitalize and observe patients at high risk for rebleeding and its complications for a minimum of 48 hours. This includes patients with any one of the following:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Risk factors for recurrent bleeding (active bleeding at the time of endoscopy, portal hypertension, coagulopathy).</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Endoscopic stigmata of recent bleeding (eg, non-bleeding visible vessel or adherent clot).</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Severe upper gastrointestinal bleeding (hemodynamic instability, hematochezia, blood transfusion requirement).</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Increased risk for complications should bleeding recur (eg, significant coronary artery or cerebrovascular disease, age over 65 years, patients taking antiplatelet or anticoagulant medications). </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In patients without risk factors for rebleeding, endoscopic stigmata of recent bleeding or clinical features indicating severe bleeding, we suggest discharge following endoscopy on a standard-dose proton pump inhibitor rather than admission to the hospital for observation (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). Almost all such patients will heal spontaneously. (See <a href=\"#H3045770783\" class=\"local\">'Inpatient versus outpatient management'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Approximately 7 percent of patients with Mallory&ndash;Weiss syndrome have recurrent bleeding. We suggest that patients who fail endoscopic therapy undergo transarterial angiographic embolization rather than surgery (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). (See <a href=\"#H3881341551\" class=\"local\">'Treatment of persistent and recurrent bleeding'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mallory-Weiss syndrome tears heal rapidly in the absence of portal hypertensive gastropathy. Patients do not require repeat endoscopic evaluation to document healing. Approximately 40 to 70 percent of patients with Mallory-Weiss syndrome require blood transfusions. The mortality rate is approximately 5 percent and depends upon patient age and the presence of coexisting medical conditions. </p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/1\" class=\"nounderline abstract_t\">Mallory GK, Weiss S. Hemorrhages from lacerations of the cardiac orifice of the stomach due to vomiting. Am J Med Sci 1929; 178:506.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/2\" class=\"nounderline abstract_t\">Weaver DH, Maxwell JG, Castleton KB. Mallory-Weiss syndrome. Am J Surg 1969; 118:887.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/3\" class=\"nounderline abstract_t\">Watts HD, Admirand WH. Mallory-Weiss syndrome. A reappraisal. JAMA 1974; 230:1674.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/4\" class=\"nounderline abstract_t\">Michel L, Serrano A, Malt RA. Mallory-Weiss syndrome. Evolution of diagnostic and therapeutic patterns over two decades. Ann Surg 1980; 192:716.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/5\" class=\"nounderline abstract_t\">Santoro MJ, Chen YK, Collen MJ. Polyethylene glycol electrolyte lavage solution-induced Mallory-Weiss tears. Am J Gastroenterol 1993; 88:1292.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/6\" class=\"nounderline abstract_t\">Guelrud M, Torres E, Vezga MA. Miss rate of Mallory-Weiss tear after polyethylene glycol electrolyte lavage solution (abstract). Gastrointest Endosc 1998; 47:A51.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/7\" class=\"nounderline abstract_t\">Penston JG, Boyd EJ, Wormsley KG. Mallory-Weiss tears occurring during endoscopy: a report of seven cases. Endoscopy 1992; 24:262.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/8\" class=\"nounderline abstract_t\">Dagradi AE, Broderick JT, Juler G, et al. The Mallory-Weiss syndrome and lesion. A study of 30 cases. Am J Dig Dis 1966; 11:710.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/9\" class=\"nounderline abstract_t\">Harris JM, DiPalma JA. Clinical significance of Mallory-Weiss tears. Am J Gastroenterol 1993; 88:2056.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/10\" class=\"nounderline abstract_t\">Knauer CM. Mallory-Weiss syndrome. Characterization of 75 Mallory-weiss lacerations in 528 patients with upper gastrointestinal hemorrhage. Gastroenterology 1976; 71:5.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/11\" class=\"nounderline abstract_t\">Sugawa C, Benishek D, Walt AJ. Mallory-Weiss syndrome. A study of 224 patients. Am J Surg 1983; 145:30.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/12\" class=\"nounderline abstract_t\">Paquet KJ, Mercado-Diaz M, Kalk JF. Frequency, significance and therapy of the Mallory-Weiss syndrome in patients with portal hypertension. Hepatology 1990; 11:879.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/13\" class=\"nounderline abstract_t\">Schuman BM, Threadgill ST. The influence of liver disease and portal hypertension on bleeding in Mallory-Weiss syndrome. J Clin Gastroenterol 1994; 18:10.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/14\" class=\"nounderline abstract_t\">Corral JE, Keihanian T, Kr&ouml;ner PT, et al. Mallory Weiss syndrome is not associated with hiatal hernia: a matched case-control study. Scand J Gastroenterol 2017; 52:462.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/15\" class=\"nounderline abstract_t\">Cannon RA, Lee G, Cox KL. Gastrointestinal hemorrhage due to Mallory-Weiss syndrome in an infant. J Pediatr Gastroenterol Nutr 1985; 4:323.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/16\" class=\"nounderline abstract_t\">Fishman ML, Thirlwell MP, Daly DS. Mallory-Weiss tear. A complication of cancer chemotherapy. Cancer 1983; 52:2031.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/17\" class=\"nounderline abstract_t\">Shimoda R, Iwakiri R, Sakata H, et al. Endoscopic hemostasis with metallic hemoclips for iatrogenic Mallory-Weiss tear caused by endoscopic examination. Dig Endosc 2009; 21:20.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/18\" class=\"nounderline abstract_t\">De Vries AJ, van der Maaten JM, Laurens RR. Mallory-Weiss tear following cardiac surgery: transoesophageal echoprobe or nasogastric tube? Br J Anaesth 2000; 84:646.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/19\" class=\"nounderline abstract_t\">Lee S, Ahn JY, Jung HY, et al. Effective endoscopic treatment of Mallory-Weiss syndrome using Glasgow-Blatchford score and Forrest classification. J Dig Dis 2016; 17:676.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/20\" class=\"nounderline abstract_t\">Banerjee S, Bellamkonda S, Gumaste VV. The Blatchford score is an useful index in the management of Mallory-Weiss tear and gastrointestinal bleeding: experience from an urban community hospital. Acta Gastroenterol Belg 2012; 75:432.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/21\" class=\"nounderline abstract_t\">Barkun AN, Bardou M, Kuipers EJ, et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2010; 152:101.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/22\" class=\"nounderline abstract_t\">Laine L. Multipolar electrocoagulation in the treatment of active upper gastrointestinal tract hemorrhage. A prospective controlled trial. N Engl J Med 1987; 316:1613.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/23\" class=\"nounderline abstract_t\">Yamaguchi Y, Yamato T, Katsumi N, et al. Endoscopic hemoclipping for upper GI bleeding due to Mallory-Weiss syndrome. Gastrointest Endosc 2001; 53:427.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/24\" class=\"nounderline abstract_t\">Yuan Y, Wang C, Hunt RH. Endoscopic clipping for acute nonvariceal upper-GI bleeding: a meta-analysis and critical appraisal of randomized controlled trials. Gastrointest Endosc 2008; 68:339.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/25\" class=\"nounderline abstract_t\">Huang SP, Wang HP, Lee YC, et al. Endoscopic hemoclip placement and epinephrine injection for Mallory-Weiss syndrome with active bleeding. Gastrointest Endosc 2002; 55:842.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/26\" class=\"nounderline abstract_t\">Wong RM, Ota S, Katoh A, et al. Endoscopic ligation for non-esophageal variceal upper gastrointestinal hemorrhage. Endoscopy 1998; 30:774.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/27\" class=\"nounderline abstract_t\">Abi-Hanna D, Williams SJ, Gillespie PE, Bourke MJ. Endoscopic band ligation for non-variceal non-ulcer gastrointestinal hemorrhage. Gastrointest Endosc 1998; 48:510.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/28\" class=\"nounderline abstract_t\">Matsui S, Kamisako T, Kudo M, Inoue R. Endoscopic band ligation for control of nonvariceal upper GI hemorrhage: comparison with bipolar electrocoagulation. Gastrointest Endosc 2002; 55:214.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/29\" class=\"nounderline abstract_t\">Park CH, Min SW, Sohn YH, et al. A prospective, randomized trial of endoscopic band ligation vs. epinephrine injection for actively bleeding Mallory-Weiss syndrome. Gastrointest Endosc 2004; 60:22.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/30\" class=\"nounderline abstract_t\">Lecleire S, Antonietti M, Iwanicki-Caron I, et al. Endoscopic band ligation could decrease recurrent bleeding in Mallory-Weiss syndrome as compared to haemostasis by hemoclips plus epinephrine. Aliment Pharmacol Ther 2009; 30:399.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/31\" class=\"nounderline abstract_t\">Bataller R, Llach J, Salmer&oacute;n JM, et al. Endoscopic sclerotherapy in upper gastrointestinal bleeding due to the Mallory-Weiss syndrome. Am J Gastroenterol 1994; 89:2147.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/32\" class=\"nounderline abstract_t\">Cho YS, Chae HS, Kim HK, et al. Endoscopic band ligation and endoscopic hemoclip placement for patients with Mallory-Weiss syndrome and active bleeding. World J Gastroenterol 2008; 14:2080.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/33\" class=\"nounderline abstract_t\">Kovacs TO, Jensen DM. Endoscopic diagnosis and treatment of bleeding Mallory-Weiss tears. Gastrointest Endosc Clin North Am 1991; 1:387.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/34\" class=\"nounderline abstract_t\">Llach J, Elizalde JI, Guevara MC, et al. Endoscopic injection therapy in bleeding Mallory-Weiss syndrome: a randomized controlled trial. Gastrointest Endosc 2001; 54:679.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/35\" class=\"nounderline abstract_t\">Bharucha AE, Gostout CJ, Balm RK. Clinical and endoscopic risk factors in the Mallory-Weiss syndrome. Am J Gastroenterol 1997; 92:805.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/36\" class=\"nounderline abstract_t\">Dill JE, Wells RF. Use of vasopressin in the Mallory-Weiss syndrome. N Engl J Med 1971; 284:852.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/37\" class=\"nounderline abstract_t\">Skok P. Fatal hemorrhage from a giant Mallory-Weiss tear. Endoscopy 2003; 35:635.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/38\" class=\"nounderline abstract_t\">Kortas DY, Haas LS, Simpson WG, et al. Mallory-Weiss tear: predisposing factors and predictors of a complicated course. Am J Gastroenterol 2001; 96:2863.</a></li><li><a href=\"https://www.uptodate.com/contents/mallory-weiss-syndrome/abstract/39\" class=\"nounderline abstract_t\">Ljubi&#269;i&#263; N, Budimir I, Pavi&#263; T, et al. Mortality in high-risk patients with bleeding Mallory-Weiss syndrome is similar to that of peptic ulcer bleeding. Results of a prospective database study. Scand J Gastroenterol 2014; 49:458.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 2272 Version 10.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H9\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H1951666247\" id=\"outline-link-H1951666247\">EPIDEMIOLOGY</a></li><li><a href=\"#H2568211429\" id=\"outline-link-H2568211429\">ETIOLOGY AND PATHOGENESIS</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">CLINICAL MANIFESTATIONS</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">DIAGNOSIS</a><ul><li><a href=\"#H2751608317\" id=\"outline-link-H2751608317\">Upper endoscopy</a></li></ul></li><li><a href=\"#H3896917148\" id=\"outline-link-H3896917148\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H3605213667\" id=\"outline-link-H3605213667\">INITIAL MANAGEMENT</a><ul><li><a href=\"#H1760946791\" id=\"outline-link-H1760946791\">Overview</a></li><li><a href=\"#H3045770783\" id=\"outline-link-H3045770783\">Inpatient versus outpatient management</a></li><li><a href=\"#H4271639672\" id=\"outline-link-H4271639672\">Pharmacologic therapy for all patients</a><ul><li><a href=\"#H2647541781\" id=\"outline-link-H2647541781\">- Acid suppression</a></li><li><a href=\"#H4074434499\" id=\"outline-link-H4074434499\">- Antiemetics</a></li></ul></li><li><a href=\"#H3045402223\" id=\"outline-link-H3045402223\">Endoscopic therapy for patients with active bleeding</a></li></ul></li><li><a href=\"#H3881341551\" id=\"outline-link-H3881341551\">TREATMENT OF PERSISTENT AND RECURRENT BLEEDING</a></li><li><a href=\"#H3537167\" id=\"outline-link-H3537167\">PROGNOSIS</a></li><li><a href=\"#H1986206053\" id=\"outline-link-H1986206053\">RESUMPTION OF ANTICOAGULANTS AND ANTIPLATELET AGENTS</a></li><li><a href=\"#H3260238603\" id=\"outline-link-H3260238603\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"GAST/2272|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=GAST/57049\" class=\"graphic graphic_picture\">- Mallory Weiss tear Endosc</a></li><li><a href=\"image.htm?imageKey=GAST/76980\" class=\"graphic graphic_picture\">- Mallory Weiss muscularis Endosc</a></li><li><a href=\"image.htm?imageKey=GAST/68239\" class=\"graphic graphic_picture\">- Mallory Weiss clot Endosc</a></li><li><a href=\"image.htm?imageKey=GAST/71690\" class=\"graphic graphic_picture\">- Bleeding Mallory Weiss Endosc</a></li></ul></li></ul></div></div><div><h2>CALCULATORS</h2><div id=\"outlineCalculators\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=calculator-rockall-score-for-upper-gastrointestinal-bleeding-in-adults\" title=\"calculator 1\" class=\"calc calc_professional\">Calculator: Rockall score for upper gastrointestinal bleeding in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=calculator-blatchford-score-for-gastrointestinal-bleeding-in-adults\" title=\"calculator 2\" class=\"calc calc_professional\">Calculator: Blatchford score for gastrointestinal bleeding in adults</a></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=angiographic-control-of-nonvariceal-gastrointestinal-bleeding-in-adults\" class=\"medical medical_review\">Angiographic control of nonvariceal gastrointestinal bleeding in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-acute-upper-gastrointestinal-bleeding-in-adults\" class=\"medical medical_review\">Approach to acute upper gastrointestinal bleeding in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-adult-with-nausea-and-vomiting\" class=\"medical medical_review\">Approach to the adult with nausea and vomiting</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=boerhaave-syndrome-effort-rupture-of-the-esophagus\" class=\"medical medical_review\">Boerhaave syndrome: Effort rupture of the esophagus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=causes-of-upper-gastrointestinal-bleeding-in-adults\" class=\"medical medical_review\">Causes of upper gastrointestinal bleeding in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-gastroesophageal-reflux-in-adults\" class=\"medical medical_review\">Clinical manifestations and diagnosis of gastroesophageal reflux in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=contact-thermal-devices-for-the-treatment-of-bleeding-peptic-ulcers\" class=\"medical medical_review\">Contact thermal devices for the treatment of bleeding peptic ulcers</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=endoclip-therapy-in-the-gastrointestinal-tract-bleeding-lesions-and-beyond\" class=\"medical medical_review\">Endoclip therapy in the gastrointestinal tract: Bleeding lesions and beyond</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=endoscopic-variceal-ligation\" class=\"medical medical_review\">Endoscopic variceal ligation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=herpes-simplex-virus-infection-of-the-esophagus\" class=\"medical medical_review\">Herpes simplex virus infection of the esophagus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hiatus-hernia\" class=\"medical medical_review\">Hiatus hernia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-anticoagulants-in-patients-undergoing-endoscopic-procedures\" class=\"medical medical_review\">Management of anticoagulants in patients undergoing endoscopic procedures</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-antiplatelet-agents-in-patients-undergoing-endoscopic-procedures\" class=\"medical medical_review\">Management of antiplatelet agents in patients undergoing endoscopic procedures</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=medication-induced-esophagitis\" class=\"medical medical_review\">Medication-induced esophagitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-treatment-of-bleeding-peptic-ulcers\" class=\"medical medical_review\">Overview of the treatment of bleeding peptic ulcers</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-gastrointestinal-bleeding-in-adults\" class=\"medical medical_society_guidelines\">Society guideline links: Gastrointestinal bleeding in adults</a></li></ul></div></div>","javascript":null}